-
A global study shows that strong social relationships can improve your health
Time of Update: 2023-02-01
The results showed that only contact with family, not with other groups, was associated with active participation in behaviors that improved health; Examples in this context include washing hands, wearing masks, and social distancing.
-
Molecular Psychiatry: The first large-sample clinical study shows that high polygenic risk scores
Time of Update: 2023-02-01
In people with brain Aβ deposition, the higher the ADHD-PRS score, the faster the decline in overall cognitive function and memory cognitive domain functionIn summary, this study cleverly uses ADHD-PRS score instead of the diagnosis of ADHD, and finds that ADHD-PRS score is a risk factor for cognitive decline, which can be used as an important reference value for clinically combining genetic and imaging information to predict cognitive decline in the elderly.
-
The Chinese Academy of Thermal Sciences has made new progress in the study of the common mechanism of low temperature and drought response of bananas
Time of Update: 2023-02-01
Recently, the banana genetic improvement research team of the Institute of Biology of the Chinese Academy of Thermal Sciences/Haikou Station has made new progress in the study of the common mechanism of banana low temperature and drought response, confirming the molecular mechanism of MaDREB1F transcription factor conferring low temperature and drought stress resistance in bananas by co-regulating hormone synthesis and protective metabolite content, which provides a theoretical basis and excellent genetic resources for banana stress resistance molecular breeding.
-
Application and performance study of graphene in anti-corrosion coatings
Time of Update: 2023-02-01
0 IntroductionFrom the discovery of graphene in 2004 to 2010, the research on nano-two-dimensional graphene has made great progress. Graphene peeled from graphite is a two-dimensional crystal, in addi
-
Lei Xiaoguang's team completed the first biomimetic total synthesis and biological mechanism study of the natural product Fargesone A
Time of Update: 2023-02-01
As an important member of the nuclear receptor family, Farnesoid X receptor FXR (Farnesoid X Receptor) is highly expressed in the liver and small intestine, and has an important regulatory function f
-
Shanton has screened the first subjects in the Phase II.b study of SAP-001 refractory/tophi gout
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];Shanton Pharma, a clinical-stage biotechnology company that has developed a breakthrough treatment for patients with refractory/tophi gout, announced the launch of the RID GOUT study, a Phase IIb study of Shanton's investigational drug, SAP-001, on January 9.
-
completed and obtained the clinical study (IIT) summary report initiated by the investigator
Time of Update: 2023-02-01
js?cdnversion='+~(-new Date()/36e5)];In order to evaluate the efficacy and safety of GST-HG171 (proposed Chinese generic name "Taiatevir") combined with ritonavir (collectively referred to as "Taizhongding") in patients with the new crown of Fujian Guangsheng Zhonglin Biotechnology Co.
-
NEJM: The new "burden-free" study method found that both antihypertensive drugs were equally effective
Time of Update: 2023-02-01
Researchers at the University of Minnesota School of Medicine, in collaboration with Veterans Affairs, published a large clinical trial in the New England Journal of Medicine and found that the antihypertensive drug chlorthalidone (CTD) is no better than hydrochlorothiazide (HCTZ) at preventing cardiovascular disease or non-cancer death.
-
Aging: Studying combinations of genetic mutations may hold promise to uncover specific biomarkers of Alzheimer's disease in humans
Time of Update: 2023-02-01
Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer's disease biomarkers, Aging (2022).
Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer's disease biomarkers, Aging (2022).
-
Study Findings: Effects of Plasma or Flame Pretreatment on Bonding of Carbon Fiber Composites
Time of Update: 2023-01-28
Studies have shown that pure atmospheric plasma or flame treatment results in improved adhesion of bonded carbon fiber composite parts by up to about 45%, with only cohesive fractures observed in the adhesive during treatment .
-
SABIC Releases New Study on Automotive Rear Quarter Window Explores LEXAN™ Resin Benefits for Conformity, Styling and Aerodynamics
Time of Update: 2023-01-21
"Curved cladding, replacement of cover plates, integration of lights and more new conceptsCurved cladding, replacement of cover plates, integration of lights and more new conceptsMany of SABIC's design concepts use LEXAN resin for curved cladding that seamlessly integrates with the rest of the vehicle, while integrating accessories such as rear lighting, door locks, D-pillar trim, and even a sunroof .
-
Studies have found that the hypoglycemic drug "empagliflozin" has a mechanism of benefit for the heart, or not related to anti-inflammatory 2022 EASD
Time of Update: 2023-01-07
However, the exact mechanism remains unclear, and this study explores the effect of empagliflozin on specific plasma biomarkers and potential cardiac remodeling parameters, while determining the correlation between patients with diabetic heart failure, and in vitro experiments aim to evaluate the potential anti-inflammatory effects of empagliflozin.
-
Exercise is good medicine! Studies have found that "afternoon exercise" can significantly improve insulin resistance!
Time of Update: 2023-01-07
1007/s00125-022-05813-3[2] Afternoon or evening physical activity is linked to reduced insulin resistance, better control of blood sugar.
html[2] Afternoon or evening physical activity is linked to reduced insulin resistance, better control of blood sugar.
-
Progress of new hepatitis B drugs The first human study results of APG-1387 in the treatment of chronic hepatitis B were announced
Time of Update: 2023-01-07
Study resultsA total of 49 patients with a median age of 31 years were included, of whom 33 were male and 29 were positive for hepatitis B e antigen (HBeAg).
-
ESMO 2022 "Re-challenged" immunotherapy results after first-line treatment progress Presented at ESMO: First Phase III Study
Time of Update: 2023-01-07
Details are as follows: Professor Mustafa Ozguroglu 1 background The EMPOWER-Lung 1 study showed that cemiplimab significantly improved overall survival (OS) with an acceptable safety profile when treated with advanced NSCLC with first-line monotherapy compared with chemotherapy.